Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Adler Eric. Director active across 1 company, notably Lexeo Therapeutics, Inc.. Aggregated, 7 reports have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €19k. Activity tracked since 2 February 2024. The latest transaction was filed on 18 November 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Adler Eric is a declarant linked to Lexeo Therapeutics, Inc. (XNAS), where the listed role is Chief Medical Officer. He has 7 filings in total, and across the 7 sampled filings from 2024-02-06 to 2025-11-20, sales total EUR 18764 and purchases total EUR 0, with the modal transaction nature shown as sale.